Conference Coverage

Joint European atrial fibrillation guidelines break new ground

Publish date: October 24, 2016

 

Pages

Recommended Reading

Novel anticoagulants linked to lower intracranial hemorrhages, higher GI bleeds
MDedge Family Medicine
Not enough evidence to support LAA closure by device or surgery for atrial fib
MDedge Family Medicine
Solid INRs on warfarin don’t predict future stability
MDedge Family Medicine
VIDEO: NOACs cut intracranial bleeds in real-world atrial fib patients
MDedge Family Medicine
VIDEO: ICDs cut mortality in younger, healthier heart failure patients
MDedge Family Medicine
Commentary: INR instability in the NOAC era
MDedge Family Medicine
Trials offer lessons despite negative primary endpoints
MDedge Family Medicine
Rivaroxaban linked to more bleeding compared with dabigatran in elderly patients with nonvalvular AF
MDedge Family Medicine
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
MDedge Family Medicine
Beta-blockers curb death risk in patients with primary prevention ICD
MDedge Family Medicine